Birdwatch Note
2023-08-24 01:13:17 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
イベルメクチンは駆虫薬であり、明確な効果がでた場合、糞線虫など寄生生物駆除による効果も考えられ、ワクチン接種による有害事象の改善など断定できるものではありません https://medical.nikkeibp.co.jp/inc/all/drugdic/article/56133a775595b3d40b7965e1.htm またコロナウイルスに対する効果について、国内の販売元である興和による臨床試験でも有効性は認められず販売を断念しています https://www.chemicaldaily.co.jp/%e8%88%88%e5%92%8c%e3%80%81%e3%80%8c%e3%82%a4%e3%83%99%e3%83%ab%e3%83%a1%e3%82%af%e3%83%81%e3%83%b3%e3%80%8d%e3%81%ae%e3%82%b3%e3%83%ad%e3%83%8a%e9%81%a9%e5%bf%9c%e3%80%81%e6%9c%89%e5%8a%b9%e6%80%a7/ さらに米国FDAもイベルメクチンのCOVID19に対する効果は認めていません https://ktla.com/news/nationworld/ivermectin-still-not-effective-or-approved-for-covid-19-treatment-fda-says/ 米国では馬用のイベルメクチンを使用した事例が発生、大量接種による健康被害が出ており、注意喚起を行っています https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Written by 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1694200702409834774
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1694518204834656658
- noteId - 1694518204834656658
- participantId -
- noteAuthorParticipantId - 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858 Participant Details
- createdAtMillis - 1692839597315
- tweetId - 1694200702409834774
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- イベルメクチンは駆虫薬であり、明確な効果がでた場合、糞線虫など寄生生物駆除による効果も考えられ、ワクチン接種による有害事象の改善など断定できるものではありません https://medical.nikkeibp.co.jp/inc/all/drugdic/article/56133a775595b3d40b7965e1.htm またコロナウイルスに対する効果について、国内の販売元である興和による臨床試験でも有効性は認められず販売を断念しています https://www.chemicaldaily.co.jp/%e8%88%88%e5%92%8c%e3%80%81%e3%80%8c%e3%82%a4%e3%83%99%e3%83%ab%e3%83%a1%e3%82%af%e3%83%81%e3%83%b3%e3%80%8d%e3%81%ae%e3%82%b3%e3%83%ad%e3%83%8a%e9%81%a9%e5%bf%9c%e3%80%81%e6%9c%89%e5%8a%b9%e6%80%a7/ さらに米国FDAもイベルメクチンのCOVID19に対する効果は認めていません https://ktla.com/news/nationworld/ivermectin-still-not-effective-or-approved-for-covid-19-treatment-fda-says/ 米国では馬用のイベルメクチンを使用した事例が発生、大量接種による健康被害が出ており、注意喚起を行っています https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-08-24 01:13:17 UTC (1692839597315) |
2023-08-24 09:11:01 UTC (1692868261790) |
CURRENTLY_RATED_HELPFUL | 2023-08-25 03:41:06 UTC (1692934866410) |
CURRENTLY_RATED_HELPFUL | 2023-08-24 09:11:01 UTC (1692868261790) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-08-24 19:10:20 -0500 | Rating Details | |
2023-08-24 18:48:38 -0500 | Rating Details | |
2023-08-24 18:44:08 -0500 | Rating Details | |
2023-08-24 18:09:55 -0500 | Rating Details | |
2023-08-24 18:08:21 -0500 | Rating Details | |
2023-08-24 18:02:58 -0500 | Rating Details | |
2023-08-24 17:45:50 -0500 | Rating Details | |
2023-08-24 17:40:26 -0500 | Rating Details | |
2023-08-24 17:06:02 -0500 | Rating Details | |
2023-08-24 16:13:55 -0500 | Rating Details | |
2023-08-24 15:56:43 -0500 | Rating Details | |
2023-08-24 15:47:24 -0500 | Rating Details | |
2023-08-24 14:39:12 -0500 | Rating Details | |
2023-08-24 11:45:46 -0500 | Rating Details | |
2023-08-24 11:40:53 -0500 | Rating Details | |
2023-08-24 11:21:21 -0500 | Rating Details | |
2023-08-24 10:46:55 -0500 | Rating Details | |
2023-08-24 10:45:13 -0500 | Rating Details | |
2023-08-24 09:54:34 -0500 | Rating Details | |
2023-08-24 09:47:04 -0500 | Rating Details | |
2023-08-24 09:33:11 -0500 | Rating Details | |
2023-08-24 09:20:07 -0500 | Rating Details | |
2023-08-24 09:09:48 -0500 | Rating Details | |
2023-08-24 09:06:38 -0500 | Rating Details | |
2023-08-24 08:51:33 -0500 | Rating Details | |
2023-08-24 08:51:10 -0500 | Rating Details | |
2023-08-24 08:50:59 -0500 | Rating Details | |
2023-08-24 08:48:25 -0500 | Rating Details | |
2023-08-24 08:42:49 -0500 | Rating Details | |
2023-08-24 08:41:31 -0500 | Rating Details | |
2023-08-24 08:41:15 -0500 | Rating Details | |
2023-08-24 08:36:47 -0500 | Rating Details | |
2023-08-24 08:35:57 -0500 | Rating Details | |
2023-08-24 08:29:49 -0500 | Rating Details | |
2023-08-24 08:28:53 -0500 | Rating Details | |
2023-08-24 08:27:48 -0500 | Rating Details | |
2023-08-24 08:27:32 -0500 | Rating Details | |
2023-08-24 08:10:33 -0500 | Rating Details | |
2023-08-24 08:08:07 -0500 | Rating Details | |
2023-08-24 07:54:15 -0500 | Rating Details | |
2023-08-24 07:53:30 -0500 | Rating Details | |
2023-08-24 07:49:11 -0500 | Rating Details | |
2023-08-24 07:42:18 -0500 | Rating Details | |
2023-08-24 07:20:56 -0500 | Rating Details | |
2023-08-24 07:09:43 -0500 | Rating Details | |
2023-08-24 06:40:15 -0500 | Rating Details | |
2023-08-24 06:29:55 -0500 | Rating Details | |
2023-08-24 06:25:43 -0500 | Rating Details | |
2023-08-24 06:19:33 -0500 | Rating Details | |
2023-08-24 06:14:32 -0500 | Rating Details | |
2023-08-24 06:10:46 -0500 | Rating Details | |
2023-08-24 06:10:20 -0500 | Rating Details | |
2023-08-24 06:05:22 -0500 | Rating Details | |
2023-08-24 05:30:30 -0500 | Rating Details | |
2023-08-24 05:15:20 -0500 | Rating Details | |
2023-08-24 04:32:10 -0500 | Rating Details | |
2023-08-24 04:12:40 -0500 | Rating Details | |
2023-08-24 00:36:13 -0500 | Rating Details | |
2023-08-23 23:15:53 -0500 | Rating Details | |
2023-08-23 22:39:58 -0500 | Rating Details | |
2023-08-23 22:34:15 -0500 | Rating Details | |
2023-08-23 22:28:36 -0500 | Rating Details | |
2023-08-23 22:09:10 -0500 | Rating Details | |
2023-08-23 22:03:46 -0500 | Rating Details | |
2023-08-23 21:56:39 -0500 | Rating Details | |
2023-08-23 21:39:09 -0500 | Rating Details | |
2023-08-23 21:33:24 -0500 | Rating Details | |
2023-08-23 21:32:22 -0500 | Rating Details | |
2023-08-23 21:27:36 -0500 | Rating Details | |
2023-08-23 21:25:45 -0500 | Rating Details | |
2023-08-23 20:55:19 -0500 | Rating Details | |
2023-08-23 20:32:07 -0500 | Rating Details | |
2023-08-23 20:23:21 -0500 | Rating Details | |
2023-08-23 20:16:59 -0500 | Rating Details | |
2023-08-25 18:25:23 -0500 | Rating Details | |
2023-08-25 18:25:04 -0500 | Rating Details | |
2023-08-25 17:42:52 -0500 | Rating Details | |
2023-08-25 15:25:24 -0500 | Rating Details | |
2023-08-25 14:05:00 -0500 | Rating Details | |
2023-08-25 11:49:08 -0500 | Rating Details | |
2023-08-25 11:18:18 -0500 | Rating Details | |
2023-08-25 10:51:38 -0500 | Rating Details | |
2023-08-25 10:51:32 -0500 | Rating Details | |
2023-08-25 10:17:48 -0500 | Rating Details | |
2023-08-25 10:15:02 -0500 | Rating Details | |
2023-08-25 10:07:44 -0500 | Rating Details | |
2023-08-25 09:42:18 -0500 | Rating Details | |
2023-08-25 09:18:15 -0500 | Rating Details | |
2023-08-25 08:57:30 -0500 | Rating Details | |
2023-08-25 08:55:12 -0500 | Rating Details | |
2023-08-25 08:47:46 -0500 | Rating Details | |
2023-08-25 08:40:19 -0500 | Rating Details | |
2023-08-25 08:35:02 -0500 | Rating Details | |
2023-08-25 08:30:57 -0500 | Rating Details | |
2023-08-25 08:23:15 -0500 | Rating Details | |
2023-08-25 08:21:24 -0500 | Rating Details | |
2023-08-25 08:21:14 -0500 | Rating Details | |
2023-08-25 08:20:39 -0500 | Rating Details | |
2023-08-25 08:12:17 -0500 | Rating Details | |
2023-08-25 08:09:59 -0500 | Rating Details | |
2023-08-25 08:01:59 -0500 | Rating Details | |
2023-08-25 07:54:25 -0500 | Rating Details | |
2023-08-25 07:39:47 -0500 | Rating Details | |
2023-08-25 07:26:18 -0500 | Rating Details | |
2023-08-25 07:18:14 -0500 | Rating Details | |
2023-08-25 07:17:25 -0500 | Rating Details | |
2023-08-25 07:15:44 -0500 | Rating Details | |
2023-08-25 07:14:26 -0500 | Rating Details | |
2023-08-25 07:06:19 -0500 | Rating Details | |
2023-08-25 06:59:26 -0500 | Rating Details | |
2023-08-25 06:50:55 -0500 | Rating Details | |
2023-08-25 06:50:49 -0500 | Rating Details | |
2023-08-25 06:49:03 -0500 | Rating Details | |
2023-08-25 06:44:15 -0500 | Rating Details | |
2023-08-25 06:40:24 -0500 | Rating Details | |
2023-08-25 06:38:03 -0500 | Rating Details | |
2023-08-25 06:37:17 -0500 | Rating Details | |
2023-08-25 06:36:38 -0500 | Rating Details | |
2023-08-25 06:35:55 -0500 | Rating Details | |
2023-08-25 06:32:14 -0500 | Rating Details | |
2023-08-25 06:29:21 -0500 | Rating Details | |
2023-08-25 06:26:27 -0500 | Rating Details | |
2023-08-25 06:25:17 -0500 | Rating Details | |
2023-08-25 06:24:34 -0500 | Rating Details | |
2023-08-25 06:22:23 -0500 | Rating Details | |
2023-08-25 06:19:19 -0500 | Rating Details | |
2023-08-25 06:13:06 -0500 | Rating Details | |
2023-08-25 06:12:32 -0500 | Rating Details | |
2023-08-25 06:10:49 -0500 | Rating Details | |
2023-08-25 06:06:40 -0500 | Rating Details | |
2023-08-25 06:06:39 -0500 | Rating Details | |
2023-08-25 06:06:20 -0500 | Rating Details | |
2023-08-25 06:05:37 -0500 | Rating Details | |
2023-08-25 06:04:12 -0500 | Rating Details | |
2023-08-25 06:03:18 -0500 | Rating Details | |
2023-08-25 06:03:13 -0500 | Rating Details | |
2023-08-25 06:02:12 -0500 | Rating Details | |
2023-08-25 06:01:07 -0500 | Rating Details | |
2023-08-25 06:00:05 -0500 | Rating Details | |
2023-08-25 05:59:29 -0500 | Rating Details | |
2023-08-25 05:59:11 -0500 | Rating Details | |
2023-08-25 05:59:04 -0500 | Rating Details | |
2023-08-25 05:57:04 -0500 | Rating Details | |
2023-08-25 05:56:27 -0500 | Rating Details | |
2023-08-25 05:56:06 -0500 | Rating Details | |
2023-08-25 05:55:37 -0500 | Rating Details | |
2023-08-25 05:55:34 -0500 | Rating Details | |
2023-08-25 05:55:12 -0500 | Rating Details | |
2023-08-25 05:53:11 -0500 | Rating Details | |
2023-08-25 05:50:55 -0500 | Rating Details | |
2023-08-25 05:50:26 -0500 | Rating Details | |
2023-08-25 05:50:10 -0500 | Rating Details | |
2023-08-25 05:49:11 -0500 | Rating Details | |
2023-08-25 05:48:45 -0500 | Rating Details | |
2023-08-25 05:48:34 -0500 | Rating Details | |
2023-08-25 05:48:06 -0500 | Rating Details | |
2023-08-25 05:47:26 -0500 | Rating Details | |
2023-08-25 05:47:18 -0500 | Rating Details | |
2023-08-25 05:47:08 -0500 | Rating Details | |
2023-08-25 05:46:30 -0500 | Rating Details | |
2023-08-25 05:42:06 -0500 | Rating Details | |
2023-08-25 05:38:34 -0500 | Rating Details | |
2023-08-25 05:34:19 -0500 | Rating Details | |
2023-08-25 04:47:02 -0500 | Rating Details | |
2023-08-25 00:51:34 -0500 | Rating Details | |
2023-08-25 00:43:03 -0500 | Rating Details | |
2023-08-24 22:39:16 -0500 | Rating Details | |
2023-08-24 22:35:24 -0500 | Rating Details | |
2023-08-24 22:15:37 -0500 | Rating Details | |
2023-08-24 21:57:24 -0500 | Rating Details | |
2023-08-24 21:49:37 -0500 | Rating Details | |
2023-08-24 19:57:33 -0500 | Rating Details | |
2023-08-24 19:48:58 -0500 | Rating Details | |
2023-08-26 16:58:03 -0500 | Rating Details | |
2023-08-25 19:38:25 -0500 | Rating Details | |
2023-08-25 06:04:43 -0500 | Rating Details | |
2023-08-25 06:06:27 -0500 | Rating Details | |
2023-08-29 02:02:35 -0500 | Rating Details | |
2023-08-29 01:46:15 -0500 | Rating Details | |
2023-08-29 00:50:36 -0500 | Rating Details | |
2023-08-28 23:19:11 -0500 | Rating Details | |
2023-08-28 23:04:36 -0500 | Rating Details | |
2023-08-28 22:44:35 -0500 | Rating Details | |
2023-08-31 17:58:30 -0500 | Rating Details | |
2023-08-24 08:48:13 -0500 | Rating Details | |
2023-09-02 07:32:30 -0500 | Rating Details | |
2023-10-31 08:50:52 -0500 | Rating Details | |
2024-03-31 09:34:46 -0500 | Rating Details |